Coronavirus Insurance Denial Lawsuits Will Not Be Centralized for Pretrial Proceedings in MDL

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has denied a request to centralize and consolidate all lawsuits filed in the federal court system against insurance companies who have denied business interruption coverage following the COVID-19 pandemic, indicating that the large number of insurers involved and lack of overlapping parties in the lawsuits would result in little benefit from consolidating the cases.

Following widespread disruption throughout the U.S. economy this year due to coronavirus, thousands of small businesses nationwide have been denied insurance benefits they thought they purchased under business interruption policies, with nearly all insurance companies routinely denying that the losses are covered.

With hundreds of complaints being filed throughout the federal court system, a group of plaintiffs filed a motion to consolidate all coronavirus insurance denial lawsuits earlier this year, asking that the cases be centralized before one U.S. District Judge to reduce duplicative discovery, avoid contradictory pretrial rulings and serve the convenience of common witnesses and parties in the litigation.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Insurance companies have been denying coronavirus-related business interruption claims, arguing that the policies contain exclusions for viral outbreaks. However, plaintiffs have challenged the denials on a number of grounds, including arguments that many of the losses were not the result of illnesses, but stem from government mandated “stay home” orders.

Following oral arguments held virtually last month, the U.S. JPML issued an order denying transfer (PDF) on August 12, indicating that establishing a federal multidistrict litigation (MDL) for the coronavirus insurance lawsuits would not help move the cases through the court system more efficiently.

“There is no common defendant in these actions – indeed, there are no true multi-defendant cases, as the actions involve either a single insurer or insurer-group,” the JPML wrote, noting the cases involve at least 32 different insurers. “Thus, there is little potential for common discovery across the litigation. Furthermore, these cases involve different insurance policies with different coverages, conditions, exclusions, and policy language, purchased by different businesses in different industries located in different states. These differences will overwhelm any common factual questions.”

In complex product liability litigation, where a large number of claims are filed throughout the federal court system by individuals who suffered similar injuries as a result of the same or similar products or venues, it is common for the federal court system to centralize the litigation for pretrial proceedings. However, given the JPML’s decision, currently all of the lawsuits will proceed as individual claims.

It is estimated thousands of similar complaints will likely be filed in the coming months, as more small businesses are pushed to the brink only to find their insurance companies are denying payments on policies they purchased.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted 2 days ago)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted 2 days ago)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.